Jasper Therapeutics

Jasper Therapeutics is a clinical‑stage biotechnology company focused on developing targeted therapies to improve outcomes for patients undergoing hematopoietic cell and organ transplantation. The company works on agents designed to enhance donor cell engraftment and reduce transplant‑related complications such as graft failure and rejection. Jasper advances its programs through preclinical and clinical development and collaborates with academic centers and industry partners to bring transplant‑focused therapies to patients.